The role of stem and circulating cells in cancer metastasis

Journal of Surgical Oncology

Volumn 103, Issue 6, 2011, Pages 555-557

  Ghadially, Ruby ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

cancer stem cell; melanoma

Indexed keywords

ADAPALENE; ALDEHYDE DEHYDROGENASE;

ARTICLE; CANCER STEM CELL; HUMAN; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 79953868845     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21807     Document Type: Article

References (39)

1. Clarke MF, Dick JE, Dirks PB, et al.: Cancer stem cells-Perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66: 9339-9344. (Pubitemid 44623625)
2. Quintana E, Shackleton M, Sabel MS, et al.: Efficient tumour formation by single human melanoma cells. Nature 2008; 456: 593-598.
3. Schatton T, Murphy GF, Frank NY, et al.: Identification of cells initiating human melanomas. Nature 2008; 451: 345.
4. Jordan CT,: Cancer stem cells: Controversial or just misunderstood? Cell Stem Cell 2009; 4: 203-205.
5. Park CH, Bergsagel DE, McCulloch EA,: Mouse myeloma tumor stem cells: A primary cell culture assay. J Natl Cancer Inst 1971; 46: 411-422.
6. Bonnet D, Dick JE,: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-737. (Pubitemid 27298715)
7. Lapidot T, Sirard C, Vormoor J, et al.: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-648. (Pubitemid 24067706)
8. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al.: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988. (Pubitemid 36418143)
9. Prince ME, Sivanandan R, Kaczorowski A, et al.: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007; 104: 973-978. (Pubitemid 46154721)
10. Singh SK, Hawkins C, Clarke ID, et al.: Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401. (Pubitemid 39551674)
11. Beier D, Hau P, Proescholdt M, et al.: CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007; 67: 4010-4015. (Pubitemid 46815044)
12. O'Brien CA, Pollett A, Gallinger S, et al.: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110. (Pubitemid 46067310)
13. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al.: Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115. (Pubitemid 46067311)
14. Refaeli Y, Bhoumik A, Roop DR, et al.: Melanoma-initiating cells: A compass needed. EMBO Rep 2009; 10: 965-972.
15. Hendrix MJ, Seftor EA, Hess AR, et al.: Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma. Nat Rev Cancer 2003; 3: 411-421. (Pubitemid 37328845)
16. Klein WM, Wu BP, Zhao S, et al.: Increased expression of stem cell markers in malignant melanoma. Mod Pathol 2007; 20: 102-107. (Pubitemid 44967955)
17. van Kempen LC, van den Oord JJ, van Muijen GN, et al.: Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am J Pathol 2000; 156: 769-774. (Pubitemid 30626933)
18. Oswald J, Boxberger S, Jorgensen B, et al.: Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004; 22: 377-384. (Pubitemid 38736621)
19. Fidler IJ, Kripke ML,: Metastasis results from preexisting variant cells within a malignant tumor. Science 1977; 197: 893-895. (Pubitemid 8168759)
20. Meier F, Satyamoorthy K, Nesbit M, et al.: Molecular events in melanoma development and progression. Front Biosci 1998; 3: D1005-D1010.
21. Ackermann J, Frutschi M, Kaloulis K, et al.: Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res 2005; 65: 4005-4011. (Pubitemid 40775636)
22. Fang D, Nguyen TK, Leishear K, et al.: A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005; 65: 9328-9337. (Pubitemid 41508000)
23. Grichnik JM, Burch JA, Schulteis RD, et al.: Melanoma, a tumor based on a mutant stem cell? J Invest Dermatol 2006; 126: 142-153. (Pubitemid 43336106)
24. Monzani E, Facchetti F, Galmozzi E, et al.: Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 2007; 43: 935-946. (Pubitemid 46366698)
25. Schatton T, Frank NY, Frank MH,: Identification and targeting of cancer stem cells. Bioessays 2009; 31: 1038-1049.
26. Patrawala L, Calhoun T, Schneider-Broussard R, et al.: Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006; 25: 1696-1708.
27. Ferrone S, Marincola FM,: Loss of HLA class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995; 16: 487-494.
28. Cabrera T, Lara E, Romero JM, et al.: HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination. Cancer Immunol Immunother 2007; 56: 709-717. (Pubitemid 46348739)
29. Boiko AD, Razorenova OV, van de Rijn M, et al.: Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010; 466: 133-137.
30. Cheung AM, Wan TS, Leung JC, et al.: Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia 2007; 21: 1423-1430. (Pubitemid 46965282)
31. Ginestier C, Hur MH, Charafe-Jauffret E, et al.: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567. (Pubitemid 350056407)
32. Croker AK, Goodale D, Chu J, et al.: High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med 2008.
33. Dylla SJ, Beviglia L, Park IK, et al.: Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS ONE 2008; 3: e2428.
34. Huang EH, Hynes MJ, Zhang T, et al.: Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009; 69: 3382-3389.
35. Ma S, Chan KW, Lee TK, et al.: Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 2008; 6: 1146-1153.
36. Storms RW, Trujillo AP, Springer JB, et al.: Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA 1999; 96: 9118-9123. (Pubitemid 29374717)
37. Boonyaratanakornkit JB, Yue L, Strachan LR, et al.: Selection of tumorigenic melanoma cells using ALDH. J Invest Dermatol 2010.
38. Kelly PN, Dakic A, Adams JM, et al.: Tumor growth need not be driven by rare cancer stem cells. Science 2007; 317: 337. (Pubitemid 47106366)
39. Kennedy JA, Barabe F, Poeppl AG, et al.: Comment on "Tumor growth need not be driven by rare cancer stem cells ". Science 2007; 318: 1722 (author reply 1722).